| Hancock & Gore Ltd (HNG) ORDINARY FULLY PAID |
Industrials |
- |
Change of Company Name and ASX Code
|
27 Feb 2026 9:11AM |
$0.215 |
$0.210 |
fallen by
2.33%
|
|
| Nexsen Limited (NXN) ORDINARY FULLY PAID |
Health Care |
$17 |
Half Yearly Report and Accounts
|
27 Feb 2026 9:11AM |
$0.160 |
$0.185 |
risen by
15.63%
|
|
NXN - Price-sensitive ASX Announcement
Full Release
Key Points
- Nexsen Limited reported a loss of $4,176,587 for the half-year ending December 31, 2025.
- The loss represents a 463% increase compared to the previous year's same period.
- The company successfully listed on the ASX and raised $8 million through an IPO.
- Focus on advancing the GBS Rapid Sensor towards clinical validation and regulatory engagement.
- Expansion of the product pipeline to include kidney function diagnostics.
- Strong governance and risk management despite financial loss.
- No dividends declared for the period.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Australian Critical Minerals Limited (ACM) ORDINARY FULLY PAID |
Materials |
$6 |
Letter to Shareholders - General Meeting
|
27 Feb 2026 9:11AM |
$0.099 |
$0.050 |
fallen by
49.49%
|
|
| Ion Video Ltd (IOV) ORDINARY FULLY PAID |
Information Technology |
$28 |
1HFY26 Results Presentation
|
27 Feb 2026 9:10AM |
$0.335 |
$0.280 |
fallen by
16.42%
|
|
IOV - Price-sensitive ASX Announcement
Full Release
Key Points
- Total liabilities reduced substantially from $2.8m to $561k.
- Savings of $1.3m per year by exiting legacy contracts.
- Monthly cash burn is $180k, with funding secured until 2027.
- Share consolidation and cost control have led to a net asset positive position.
- Focusing on video superintelligence enabling infrastructure.
- Engagement with global technology partners to strengthen commercialisation.
- Patents being developed and validated for long-term security.
- Relaunch marked beginning of commercialisation phase.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Switzer Dividend Growth Fund (Managed Fund) (SWTZ) |
Financials |
$58 |
Quarterly portfolio disclosure as at 31 December 2025
|
27 Feb 2026 9:10AM |
$2.550 |
$2.500 |
fallen by
1.96%
|
|
| Zip Co Limited (ZIP) ORDINARY FULLY PAID |
Financials |
$3,167 |
Change of Director's Interest Notice - K Moss
|
27 Feb 2026 9:10AM |
$1.845 |
$2.520 |
risen by
36.59%
|
|
| Freehill Mining Limited (FHS) ORDINARY FULLY PAID |
Materials |
$6 |
Trading Halt
|
27 Feb 2026 9:10AM |
$0.003 |
$0.002 |
fallen by
50%
|
|
FHS - Price-sensitive ASX Announcement
Full Release
Key Points
- Freehill Mining Limited requested a trading halt on ASX.
- The trading halt is due to an upcoming announcement on capital raising.
- The halt will last until the announcement or 3 March 2026, whichever is earlier.
- ASX Listing Rule 17.1 was cited in the request.
- The company confirmed no other information needed for the market about the halt.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ion Video Ltd (IOV) ORDINARY FULLY PAID |
Information Technology |
$28 |
Half Yearly Report and Accounts
|
27 Feb 2026 9:10AM |
$0.335 |
$0.280 |
fallen by
16.42%
|
|
IOV - Price-sensitive ASX Announcement
Full Release
Key Points
- Net loss of $2,739,564 for the half-year ended 31 December 2025.
- Raised $4,785,709 through equity and convertible notes.
- Shifted focus to enabling infrastructure and intellectual property.
- Material uncertainty about the company's ability to continue as a going concern.
- Leadership changes with new CEO and Executive Director appointments.
- Significant capital consolidation reducing the number of shares.
- No dividends declared during the financial period.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| MPR Australia Limited (MPR) ORDINARY FULLY PAID |
Financials |
$2 |
Appendix 4D and Half Year Financial Report
|
27 Feb 2026 9:10AM |
$0.005 |
$0.005 |
fallen by
0%
|
|
| Australian Critical Minerals Limited (ACM) ORDINARY FULLY PAID |
Materials |
$6 |
Notice of General Meeting/Proxy Form
|
27 Feb 2026 9:09AM |
$0.099 |
$0.050 |
fallen by
49.49%
|
|
| Strata Investment Holdings Plc (SRT) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$27 |
Preliminary Final Report
|
27 Feb 2026 9:08AM |
$0.160 |
$0.160 |
fallen by
0%
|
|
| Fin Resources Limited (FIN) |
Materials |
$16 |
Land Use Permit Assignment Finalises Cabin Lake Acquisition
|
27 Feb 2026 9:08AM |
$0.013 |
$0.011 |
fallen by
15.38%
|
|
FIN - Price-sensitive ASX Announcement
Full Release
Key Points
- Land Use Permit for Cabin Lake Gold Project formally assigned to FIN's Canadian subsidiary.
- Final condition for acquisition of 100% interest in Cabin Lake satisfied.
- 1,500 metre diamond drilling program to commence in March 2026.
- A$3.75 million raised to fund drilling and associated geophysics.
- Cabin Lake offers high-grade near-surface exploration potential.
- Strong local engagement with the Tlic?ho Government for on-ground work.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Hydrix Limited (HYD) ORDINARY FULLY PAID |
Information Technology |
$3 |
Trading Update and Growth Outlook
|
27 Feb 2026 9:08AM |
$0.016 |
$0.012 |
fallen by
25%
|
|
HYD - Price-sensitive ASX Announcement
Full Release
Key Points
- $2.5 million contract with SynCardia for artificial heart development.
- Quarter to date sales of $3.7 million, mainly from new international clients.
- Potential future revenues of ~$40 million over 2-3 years.
- Cash on hand is $0.6 million with support via a $2.2 million Letter of Comfort.
- Focus on developing safety-critical medical devices.
- Continued management of operating expenses to support growth.
- Progress in commercial discussions for a cardiac monitoring platform.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| IODM Limited (IOD) ORDINARY FULLY PAID |
Information Technology |
$105 |
Half Yearly Report and Accounts
|
27 Feb 2026 9:08AM |
$0.170 |
$0.165 |
fallen by
2.94%
|
|
IOD - Price-sensitive ASX Announcement
Full Release
Key Points
- Total revenue for the half-year ended 31 December 2025 was $2,478,863.
- Loss after tax amounted to $791,017.
- Net cash outflow from operating activities was $783,489.
- Issued capital increased to $21,742,121 through the settlement of debt for equity.
- Accumulated losses at the end of the period were $24,217,270.
- The total equity at 31 December 2025 stood at $69,945.
- Total assets increased to $1,179,735, while total liabilities reduced to $1,109,790.
- Cash and cash equivalents at the end of the period were $570,028.
- Major revenue sources include implementation fees and license fees.
- The company operates under Australian Accounting Standards AASB 134.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Chimeric Therapeutics Limited (CHM) ORDINARY FULLY PAID |
Health Care |
$9 |
Portfolio streamlined - return of CHM CLTX to City of Hope
|
27 Feb 2026 9:08AM |
$0.002 |
$0.002 |
fallen by
0%
|
|
CHM - Price-sensitive ASX Announcement
Full Release
Key Points
- Chimeric returns CHM CLTX asset to City of Hope.
- Strategic focus shifts to CHM CDH17 program.
- Decision aligns with disciplined capital management.
- CHM CLTX development was overtaken by other assets.
- City of Hope regains control of CHM CLTX intellectual property.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Hydrix Limited (HYD) ORDINARY FULLY PAID |
Information Technology |
$3 |
Half Yearly Report and Accounts
|
27 Feb 2026 9:07AM |
$0.016 |
$0.012 |
fallen by
25%
|
|
HYD - Price-sensitive ASX Announcement
Full Release
Key Points
- Net loss of $2,340,411 for the half-year ended 31 December 2025
- Comprehensive loss totaled $2,350,797
- Revenue from contracts with customers was $4,837,519
- Significant operating expenses and cash flow challenges
- Cash used in operations was $22,383
- Directors acknowledge material uncertainties regarding going concern
- Strategic initiatives for liquidity and capital management are underway
- Hydrix Ventures' investment portfolio valued at $2.7 million
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Wisetech Global Limited (WTC) ORDINARY FULLY PAID |
Information Technology |
$15,353 |
Application for quotation of securities - WTC
|
27 Feb 2026 9:07AM |
$49.000 |
$45.680 |
fallen by
6.78%
|
|
| Alcoa Corporation (AAI) CDI 1:1 FOREIGN EXEMPT NYSE |
Materials |
$24,658 |
ASX Listing Rule 1.15.3 Confirmation
|
27 Feb 2026 9:07AM |
$90.430 |
$93.450 |
risen by
3.34%
|
|
| Harvey Norman Holdings Ltd (HVN) ORDINARY FULLY PAID |
Consumer Discretionary |
$5,744 |
Dividend/Distribution - HVN
|
27 Feb 2026 9:07AM |
$6.330 |
$4.610 |
fallen by
27.17%
|
|
| Harvey Norman Holdings Ltd (HVN) ORDINARY FULLY PAID |
Consumer Discretionary |
$5,744 |
Presentation of Results 1H26
|
27 Feb 2026 9:07AM |
$6.330 |
$4.610 |
fallen by
27.17%
|
|
HVN - Price-sensitive ASX Announcement
Full Release
Key Points
- Profit Before Tax increased by 16.5% reaching $466.31 million compared to 1H25.
- Total system sales revenue grew by 6.9% to $5.16 billion.
- Australian franchisee sales rose by 4.8% to $3.50 billion.
- Overseas retail sales increased by 11.6% to $1.66 billion.
- Property segment PBT increased by 7.8% due to revaluation increments and rental growth.
- Total assets increased to $8.77 billion as of December 31, 2025.
- Net debt-to-equity ratio remains low at 13.02%.
- Continued investment in new stores and digital transformation, with expansions in UK and Malaysia.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Harvey Norman Holdings Ltd (HVN) ORDINARY FULLY PAID |
Consumer Discretionary |
$5,744 |
Results Announcement 1H26
|
27 Feb 2026 9:06AM |
$6.330 |
$4.610 |
fallen by
27.17%
|
|
HVN - Price-sensitive ASX Announcement
Full Release
Key Points
- Profit before tax increased by 16.5% to $466.31 million.
- System sales revenue grew by 6.9% to $5.16 billion.
- Australian franchisee sales increased by 4.8%.
- Company-operated sales rose by 11.6%.
- Franchising operations profit before tax increased by 14.2%.
- Overseas retail segment profit before tax increased by 35.6%.
- Strong performances noted in New Zealand, Ireland, Slovenia, Croatia, Singapore, and Malaysia.
- Operating expenses reduced to 17.8% of system sales.
- Property segment profit before tax increased by 7.8%.
- Balance sheet strengthened with increased assets and conservative gearing.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Alcoa Corporation (AAI) CDI 1:1 FOREIGN EXEMPT NYSE |
Materials |
$24,658 |
Annual Report on Form 10-K for year ended December 31, 2025
|
27 Feb 2026 9:06AM |
$90.430 |
$93.450 |
risen by
3.34%
|
|
| Titomic Limited (TTT) ORDINARY FULLY PAID |
Materials |
$486 |
Titomic Investor Day in Huntsville
|
27 Feb 2026 9:06AM |
$0.200 |
$0.303 |
risen by
51.25%
|
|
| Noxopharm Limited (NOX) ORDINARY FULLY PAID |
Health Care |
$23 |
At-the-Market (ATM) agreement with Acuity Capital
|
27 Feb 2026 9:06AM |
$0.065 |
$0.075 |
risen by
15.38%
|
|
NOX - Price-sensitive ASX Announcement
Full Release
Key Points
- Noxopharm Limited (ASX:NOX) has signed an At-the-Market (ATM) Agreement with Acuity Capital.
- The ATM provides up to $5 million of standby equity capital available to Noxopharm over the next five years until 31 July 2031.
- Noxopharm has full discretion on whether to use the ATM, including the number of shares issued and the minimum issue price.
- The company can set a price floor, with the final issue price being the greater of the floor price or up to a 10% discount to the Volume Weighted Average Price (VWAP).
- Noxopharm has placed 15,000,000 fully paid ordinary NOX ASX shares as security for the ATM at nil cash consideration.
- Noxopharm can buy back and cancel these shares, subject to shareholder approval, if the ATM is terminated early or upon maturity.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Titomic Limited (TTT) ORDINARY FULLY PAID |
Materials |
$486 |
Appendix 4G and Corporate Governance Statement
|
27 Feb 2026 9:06AM |
$0.200 |
$0.303 |
risen by
51.25%
|
|
Call 1300 880 160
Start a chat
Schedule a call
